Cite
HARVARD Citation
Kaufman, H. et al. (2018). Updated efficacy of avelumab in patients with previously treated metastatic Merkel cell carcinoma after ≥1 year of follow-up: JAVELIN Merkel 200, a phase 2 clinical trial. Journal for immunotherapy of cancer. 6 (1), p. . [Online].